Neurava raised $2.26M in a Series Seed round led by Life Science Angels, used for pivotal usability study and FDA clearance
Neurava raised $2.26M in a Series Seed round led by Life Science Angels, used for pivotal usability study and FDA clearance
04/03/24, 1:48 PM
Location
west lafayetteMoney raised
$2.26 million
Industry
information technology
Round Type
seed
Investors
First Leaf Capital, Rivermount Ventures, Elevate Ventures, Purdue Innovates, Ucb, Life Science Angels
Neurava completed an oversubscribed Series Seed round, raising $2.26 million to develop innovative wearable devices for epilepsy monitoring to mitigate the risk of SUDEP, with the funding used for pivotal usability study, establishing manufacturing partners, and seeking FDA clearance.